EUVIMEDEUVIMED entdecken
Open Access

The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis

Yasser S Aladdin, Danah A Alqarni, Sheifa W Alamoudi, Abdulrahman A Alharbi, Waad A Fudhah, Ghaida Alghamdi, Ahmed Attar

Cureus · 25.02.2024

DOI: 10.7759/cureus.54852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 25.02.2024. Verfasst von Yasser S Aladdin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

covi-19 vaccinecovid-19disease-modifying therapiess: multiple sclerosisside effect post vaccination

Autor:innen und Institutionen

  • Neurology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU.
  • College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
  • Department of Neurology, King Abdulaziz Medical City, Jeddah, SAU.

Zitieren

APA

Aladdin, Y. S., Alqarni, D. A., Alamoudi, S. W., Alharbi, A. A., Fudhah, W. A., Alghamdi, G., & Attar, A. (2024). The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis. Cureus. https://doi.org/10.7759/cureus.54852

Vancouver

Aladdin YS, Alqarni DA, Alamoudi SW, Alharbi AA, Fudhah WA, Alghamdi G, et al. The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis. Cureus. 2024. doi:10.7759/cureus.54852

BibTeX
@article{Aladdin2024,
  author = {Aladdin, Yasser S and Alqarni, Danah A and Alamoudi, Sheifa W and Alharbi, Abdulrahman A and Fudhah, Waad A and Alghamdi, Ghaida and Attar, Ahmed},
  title = {The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.54852}
}
Kostenlos starten →